Kidney transplant recipients have traditional and nontraditional risk factors which can lead to coronary artery disease and sudden death with a functional graft loss. Aspirin has been used traditionally for prevention of cardiovascular and cerebrovascular accidents. It has beneficial effects in secondary prevention of cardiovascular events in general population. Its use for primary prophylaxis is still disputed. Bleeding and theoretical risk of nephrotoxicity are the major concerns about its use. The data on aspirin in kidney transplant population is sparse. This review will focus on various pros and cons of aspirin use for prevention of cardiovascular events in kidney transplant recipients and a way forward
BackgroundEffects of aspirin on patients with chronic kidney disease (CKD) remains unclear. This stu...
Abstract It is unclear whether aspirin is beneficial for prevention of CVD in patients with CKD. We ...
Background: Chronic kidney disease (CKD) is a major risk factor for the development of cardiovascula...
Despite the higher risk of cardiovascular events in patients with chronic kidney disease, the role o...
AimsCardiovascular disease (CVD) is the major cause of morbidity and mortality in individuals with c...
AimsCardiovascular disease (CVD) is the major cause of morbidity and mortality in individuals with c...
AimsCardiovascular disease (CVD) is the major cause of morbidity and mortality in individuals with c...
Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether ...
Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether ...
INTRODUCTION: Early postoperative renal transplant vein thrombosis results in graft loss. We evaluat...
BACKGROUND AND AIMS: Chronic kidney disease is a strong independent predictor of cardiovascular dise...
BACKGROUND AND AIMS: Chronic kidney disease is a strong independent predictor of cardiovascular dise...
BACKGROUND AND AIMS: Chronic kidney disease is a strong independent predictor of cardiovascular dise...
BACKGROUND:The association between preoperative aspirin use and postoperative acute kidney injury (A...
Objectives: Despite improvements in immunosuppressive protocols for renal transplant, long-term succ...
BackgroundEffects of aspirin on patients with chronic kidney disease (CKD) remains unclear. This stu...
Abstract It is unclear whether aspirin is beneficial for prevention of CVD in patients with CKD. We ...
Background: Chronic kidney disease (CKD) is a major risk factor for the development of cardiovascula...
Despite the higher risk of cardiovascular events in patients with chronic kidney disease, the role o...
AimsCardiovascular disease (CVD) is the major cause of morbidity and mortality in individuals with c...
AimsCardiovascular disease (CVD) is the major cause of morbidity and mortality in individuals with c...
AimsCardiovascular disease (CVD) is the major cause of morbidity and mortality in individuals with c...
Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether ...
Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether ...
INTRODUCTION: Early postoperative renal transplant vein thrombosis results in graft loss. We evaluat...
BACKGROUND AND AIMS: Chronic kidney disease is a strong independent predictor of cardiovascular dise...
BACKGROUND AND AIMS: Chronic kidney disease is a strong independent predictor of cardiovascular dise...
BACKGROUND AND AIMS: Chronic kidney disease is a strong independent predictor of cardiovascular dise...
BACKGROUND:The association between preoperative aspirin use and postoperative acute kidney injury (A...
Objectives: Despite improvements in immunosuppressive protocols for renal transplant, long-term succ...
BackgroundEffects of aspirin on patients with chronic kidney disease (CKD) remains unclear. This stu...
Abstract It is unclear whether aspirin is beneficial for prevention of CVD in patients with CKD. We ...
Background: Chronic kidney disease (CKD) is a major risk factor for the development of cardiovascula...